Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria

Eastern Mediterranean Health Journal

Volumn 13, Issue 4, 2007, Pages 961-966

  Egah, Dan Z ^a   Banwat, E B ^a   Audu, E S ^a   Iya, D ^a   Mandong, B M ^a   Anele, A A ^a   Gomwalk, N E ^a  

^a UNIVERSITY OF JOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD TRANSFUSION; CLERGY; CLINICAL TRIAL; DIAGNOSTIC VALUE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NIGERIA; PROSPECTIVE STUDY; RISK ASSESSMENT; SEROPREVALENCE; SUPERINFECTION;

ADOLESCENT; ADULT; BLOOD DONORS; CLERGY; COMORBIDITY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MASS SCREENING; NIGERIA; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SAFETY MANAGEMENT; SEROEPIDEMIOLOGIC STUDIES;

EID: 34848855056     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. AIDS epidemic update: December 2004. Geneva, Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), 2004.
2. National HIV Seroprevalence Sentinel Survey: 2003. Nigeria, Federal Ministry of Health, 2004:13 (Technical Report).
3. Bertolini DA et al. Prevalence of serological markers of hepatitis B virus in pregnant women from Parana State, Brazil. Brazilian journal of medical and biological research, 2006, 39(8):1083-90.
4. Zah MR et al. Epidemiology of hepatitis B in the Islamic Republic of Iran. Eastern Mediterranean health journal, 1996, 2(2):290-8.
5. Siresena ND, Njoku MO, Idoko JA. Hepatitis B surface antigenaemia in patients with human immunodeficiency virus-1 (HIV-1) infection in Jos, Nigeria. Nigerian medical practitioner, 2002, 41:18-20.
6. Strickland GT. Hepatitis C in developing countries. Postgraduate doctor Africa, 2002, 24:26-8.
7. Mohammed AN et al. Hepatitis C in a community in Upper Egypt: 1. Cross-sectional survey. American journal of tropical medicine and hygiene, 2000, 63(5,6):236-41.
8. Blood safety and HIV. UNAIDS technical update. Geneva, United Nations Programme on HIV/AIDS (UNAIDS), 1997.
9. Mvere DA. A strategy for blood safety in the African Region. Africa health, 2002, 24:9-11.
10. Transfusion transmitted diseases (http://www.bloodbook.com/ trans-tran.html, accessed 7 February 2007).
11. David-West AS. Blood transfusion and blood bank management in a tropical country. Clinics in haematology, 1981, 3: 1013-28.
12. Montagnier L et al. A new type of retrovirus from patients with lymphadenopathy and acquired immune deficiency syndrome structural and antigenic relatedness with equine infections anemia virus. Annals of virology, 1984, 135E:119-34.
13. Besley ET. Window period for HIV infected blood. Nigeria AIDS monitor, 1994, 2:11.
14. Healthlink Network. Blood safety. AIDS action, Issue 34, 1996 (http://www.aids-action.info/aa/aa34.html#top, accessed 7 February 2007).
15. Audu ES. Seroprevalence of antibodies to hepatitis C virus among blood donors in Jos [Dissertation]. Lagos, National Postgraduate Medical College of Nigeria, 2000.
16. Halim NKD, Offor E, Ajayi OI. Epidemiologic study of the seroprevalence of hepatitis B surface antigen (HBsAg) and HIV-1 in blood donors. Nigerian journal of clinical practice, 1999, 2:42-5.
17. Durosinmi MA at al. Prevalence of HIV-1 and HbsAg in normal blood donors in Ile-Ife. Nigerian medical journal, 1991, 21:138-40.
18. Egah DZ et al. Hepatitis C virus antibodies among blood donors in Jos, Nigeria. Annals of African medicine, 2004, 3:35-7.
19. Zou S et al. Probability of viremia with HBV, HCV, HIV and HTLV among tissue donors in the United States. New England journal of medicine, 2004, 351:751-9.
20. Goncales Jr FL et al. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus. Clinical and diagnostic laboratory immunology, 2003, 10:718-20.
21. Goodman JL. The safety and availability of blood and tissues - progress and challenges. New England journal of medicine, 2004, 351:819-22.
22. Ahmed SG. Laboratory strategic defense initiatives against transmission of human immune deficiency virus in blood and blood products. Nigerian postgraduate medical journal, 2003, 10:254-9.